Sequent Scientific Ltd

BOM:512529 (India)  
₹ 175.75 (+0.77%) Dec 24
266.29
P/B:
6.44
Market Cap:
₹ 43.58B ($ 514.35M)
Enterprise V:
₹ 47.72B ($ 570.11M)
Volume:
10.45K
Avg Vol (2M):
46.71K
Warning! GuruFocus detected 2 Severe warning signs with 512529. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
10.45K
Market Cap ₹:
43.58B
Market Cap $:
514.35M
266.29
Avg Vol (2M):
46.71K
Enterprise Value ₹:
47.72B
Enterprise Value $:
570.11M
PB Ratio:
6.44
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Sequent Scientific Ltd

ISIN : INE807F01027
https://www.sequent.in
Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604
Compare
Compare
BOM:500288BOM:509079BOM:524735BOM:524348BOM:543748BOM:506690NSE:RPGLIFEBOM:506879NSE:INNOVACAPBOM:541540ZTSXTER:MRKNSE:SUNPHARMALSE:HLNTSE:4502XSWX:GALDXTAE:TEVANSE:DIVISLABXSWX:SDZVTRS
Traded in other countries / regions
512529.India
IPO Date
1991-06-18
Description
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Financial Strength

5/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.15
Equity-to-Asset 0.44
Debt-to-Equity 0.72
Debt-to-EBITDA 3.41
Interest Coverage 1.86
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.54
Distress
Grey
Safe
Beneish M-Score -2.78
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

4/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 0.1
3-Year EBITDA Growth Rate -36.5
3-Year Book Growth Rate -3.5

Momentum Rank

9/10
Name Current Vs Industry Vs History
5-Day RSI 22.31
9-Day RSI 30.38
14-Day RSI 37.2
6-1 Month Momentum % 70.72
12-1 Month Momentum % 70.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.7
Quick Ratio 0.96
Cash Ratio 0.15
Days Inventory 150.09
Days Sales Outstanding 82.98
Days Payable 114.3

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1
Shareholder Yield % -0.83

Profitability Rank

5/10
Name Current Vs Industry Vs History
Gross Margin % 42.04
Operating Margin % 6.95
Net Margin % 1.14
FCF Margin % -0.01
ROE % 2.51
ROA % 1.07
ROIC % 9.57
ROC (Joel Greenblatt) % 10.5
ROCE % 8.12
Years of Profitability over Past 10-Year 5

GF Value Rank

6/10
Name Current Vs Industry Vs History
PE Ratio 266.29
PE Ratio without NRI 269.15
Shiller PE Ratio 66.93
PS Ratio 3.09
PB Ratio 6.44
Price-to-Tangible-Book 11.63
Price-to-Operating-Cash-Flow 143.58
EV-to-EBIT 62.36
EV-to-Forward-EBIT 26.01
EV-to-EBITDA 33.96
EV-to-Forward-EBITDA 17.25
EV-to-Revenue 3.37
EV-to-Forward-Revenue 1.77
EV-to-FCF -22508.71
Price-to-Projected-FCF 5.8
Price-to-Median-PS-Value 1.2
Price-to-Graham-Number 11.8
Earnings Yield (Greenblatt) % 1.61
Forward Rate of Return (Yacktman) % 12.97

Financials (Next Earnings Date:2025-02-13 Est.)

BOM:512529's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sequent Scientific Ltd Executives

Details

GF Value: ₹114.17

BOM:512529

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₹) 14,459.85
EPS (TTM) (₹) 0.66
Beta 2.17
Volatility % 64.58
14-Day RSI 37.2
14-Day ATR (₹) 9.549201
20-Day SMA (₹) 193.135
12-1 Month Momentum % 70.72
52-Week Range (₹) 91.85 - 240.9
Shares Outstanding (Mil) 249.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sequent Scientific Ltd Filings

Filing Date Document Date Form
No Filing Data

Sequent Scientific Ltd Stock Events

Financials Calendars
Event Date Price(₹)
No Event Data

Sequent Scientific Ltd Frequently Asked Questions

What is Sequent Scientific Ltd(BOM:512529)'s stock price today?
The current price of BOM:512529 is ₹175.75. The 52 week high of BOM:512529 is ₹240.90 and 52 week low is ₹91.85.
When is next earnings date of Sequent Scientific Ltd(BOM:512529)?
The next earnings date of Sequent Scientific Ltd(BOM:512529) is 2025-02-13 Est..
Does Sequent Scientific Ltd(BOM:512529) pay dividends? If so, how much?
Sequent Scientific Ltd(BOM:512529) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.